Overview / Abstract: |
Target Audience This educational program is directed toward hematologists. Primary care physicians, nurse practitioners, physician assistants, and other health care professionals involved in the treatment of patients with VWD are also invited to participate. Activity Overview This online, on-demand virtual symposium brings together renowned experts with experience providing frontline care to patients with von Willebrand disease (VWD). In this educational program, these experts discuss the pathophysiology and clinical picture for the various VWD phenotypes; share insights on the application of the recently released 2021 consensus guidelines for VWD management; provide practical advice for handling challenging cases; and forecast future developments. Learning Objectives Upon successful completion of this activity, you should be better prepared to: Discuss the genotypic and phenotypic presentation of VWD based on pathophysiology |
Expiration |
Apr 20, 2022 |
Discipline(s) |
Physician CME |
Format |
Online |
Credits / Hours |
1.0 AMA PRA Category 1 Credit(s)™ |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Faculty FACULTY_NAME FACULTY_NAME FACULTY_NAME |
Sponsors / Supporters / Grant Providers |
Takeda Pharmaceuticals USA, Inc. |
Keywords / Search Terms |
Relias LLC Relias LLC., FreeCME., von Willebrand Disease Free CE CME |